title: Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation.
authors.forename: K
authors.initials: K
authors.lastname: Hussein
authors.forename: O
authors.initials: O
authors.lastname: Bock
authors.forename: K
authors.initials: K
authors.lastname: Theophile
authors.forename: A
authors.initials: A
authors.lastname: Seegers
authors.forename: H
authors.initials: H
authors.lastname: Arps
authors.forename: O
authors.initials: O
authors.lastname: Basten
authors.forename: K-H
authors.initials: KH
authors.lastname: Grips
authors.forename: J
authors.initials: J
authors.lastname: Franz-Werner
authors.forename: G
authors.initials: G
authors.lastname: Büsche
authors.forename: H
authors.initials: H
authors.lastname: Kreipe
mesh_terms: D000328:Adult; D002908:Chronic Disease; D002999:Clone Cells; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000235:genetics* / Q000473:pathology
chemical_list: D016044:Fusion Proteins, bcr-abl; C507924:JAK2 protein, human; D053614:Janus Kinase 2